John Anthony Naval, ARNP | |
16045 1st Ave S, Burien, WA 98148-1401 | |
(231) 924-6095 | |
Not Available |
Full Name | John Anthony Naval |
---|---|
Gender | Male |
Speciality | Nurse Practitioner - Family |
Location | 16045 1st Ave S, Burien, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457975559 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | 4704338680 (Michigan) | Secondary |
363LF0000X | Nurse Practitioner - Family | AP61182423 (Washington) | Primary |
Entity Name | Franciscan Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093165334 PECOS PAC ID: 0547173866 Enrollment ID: O20031111000789 |
News Archive
A novel discovery by researchers at NYU Langone Medical Center and colleagues reveals a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus' progression to AIDS. The study appears online ahead of print today in Nature Immunology.
STERIS Corporation was notified on December 3, 2009 that the U.S. Food and Drug Administration (FDA) had issued a notice to healthcare facility administrators regarding the regulatory status of the STERIS SYSTEM 1® Sterile Processing System, as well as actions healthcare facilities should take if they use this device.
The plan, advanced by Rep. Allyson Schwartz, D-Pa., would prevent a 27.4 percent cut in Medicare physician payments from kicking in Jan. 1, phase out the current outdated formula and transition to a new one. Though some physician groups are lining up behind her approach, the American Medical Association has not yet "on board."
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
John Anthony Naval, ARNP 16045 1st Ave S Fl 1, Burien, WA 98148-1401 Ph: () - | John Anthony Naval, ARNP 16045 1st Ave S, Burien, WA 98148-1401 Ph: (231) 924-6095 |
News Archive
A novel discovery by researchers at NYU Langone Medical Center and colleagues reveals a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus' progression to AIDS. The study appears online ahead of print today in Nature Immunology.
STERIS Corporation was notified on December 3, 2009 that the U.S. Food and Drug Administration (FDA) had issued a notice to healthcare facility administrators regarding the regulatory status of the STERIS SYSTEM 1® Sterile Processing System, as well as actions healthcare facilities should take if they use this device.
The plan, advanced by Rep. Allyson Schwartz, D-Pa., would prevent a 27.4 percent cut in Medicare physician payments from kicking in Jan. 1, phase out the current outdated formula and transition to a new one. Though some physician groups are lining up behind her approach, the American Medical Association has not yet "on board."
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. announced that the Phase 3 VELOUR clinical trial of aflibercept (VEGF Trap) in patients with metastatic colorectal cancer (mCRC) will continue to completion as planned, with no modifications due to efficacy or safety concerns. This decision is based on the recommendation of an Independent Data Monitoring Committee (IDMC) following a planned interim analysis.
› Verified 2 days ago
Kevin Michael Trippe, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16251 Sylvester Rd Sw, Burien, WA 98166 Phone: 253-426-6341 Fax: 253-426-6344 | |
Lior Habinsky, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15870 1st Ave S # 106, Burien, WA 98148 Phone: 206-242-2501 | |
Patricia Merenda, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16259 Sylvester Rd Sw, Suite 401, Burien, WA 98166 Phone: 206-242-8837 | |
Tatyana Ivanovna Vasilishin, DNP, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 16233 Sylvester Rd Sw Ste 260, Burien, WA 98166 Phone: 206-835-7400 Fax: 206-835-7439 | |
Mr. Robert Anthony Yap, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12459 Ambaum Blvd S.w., Unit A, Burien, WA 98146 Phone: 206-403-1819 Fax: 206-588-2752 | |
Paul T. Wilson-grills, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1210 Sw 136th St, Burien, WA 98166 Phone: 206-257-6600 Fax: 206-257-6830 | |
Ms. Dee Dee Vasquez, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1210 Sw 136th St, Burien, WA 98166 Phone: 206-257-6600 |